Results
1 -
10 of
147Surleraux Dominique L. N. G..
Design of HIV-1 Protease Inhibitors Active on Multidrug-Resistant Virus, Journal of Medicinal Chemistry, 2005 De Meyer S..
TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates, Antimicrobial Agents and Chemotherapy, 2005 Gong-Xing He, Zheng-Yu Yang, Matthew Williams, Christian Callebaut, Tomas Cihlar, Bernard P. Murray, Chris Yang, Michael L. Mitchell, Hongtao Liu, Jianying Wang, Murty Arimilli, Eugene Eisenberg, Kirsten M. Stray, Luong K. Tsai, Marcos Hatada, Xiaowu Chen, James M. Chen, Yujin Wang, Melody S. Lee, Robert G. Strickley, Quynh Iwata, Xubin Zheng, Choung U. Kim, Swami Swaminathan, Manoj C. Desai, William A. Lee and Lianhong Xu.
Discovery of GS-8374, a potent human immunodeficiency virus type 1 protease inhibitor with a superior resistance profile, Med. Chem. Commun., 2011, 2, 1093. Postoperative Bleeding After Administration of a Single Dose of Rivaroxaban to a Patient Receiving Antiretroviral Therapy, Drug Safety - Case Reports Drug Interactions in HIV: Protease and Integrase Inhibitors, Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions Drug Interactions with Antiretrovirals for HIV Infection, Drug Interactions in Infectious Diseases Decomposing the Energetic Impact of Drug-Resistant Mutations: The Example of HIV-1 Protease?DRV Binding, Computational Drug Discovery and Design